-
-
-
-
-
-
-
Neurogene Appoints Christy Shafer as Chief Commercial Officer and Christine Mikail, J.D., to Board of Directors
-
-
-
-
-
-
-
Neurogene Announces Positive Regulatory Update for NGN-401 Gene Therapy in Rett Syndrome with Plans to Initiate Dosing in Embolden™ Registrational Trial in Q4 2025
-
-
-
-
-
-
-
Neurogene Announces Appointment of Julie Jordan, M.D., as Chief Medical Officer
-
-
-
-
1,159,127 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

